000 01374 a2200409 4500
005 20250518074806.0
264 0 _c20200512
008 202005s 0 0 eng d
022 _a1757-790X
024 7 _a10.1136/bcr-2019-231830
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPatel, Ashka
245 0 0 _aNone
_h[electronic resource]
260 _bBMJ case reports
_cDec 2019
500 _aPublication Type: Case Reports; Journal Article
650 0 4 _aAdjuvants, Immunologic
_xadministration & dosage
650 0 4 _aAdministration, Intravesical
650 0 4 _aAged, 80 and over
650 0 4 _aAnimals
650 0 4 _aAntitubercular Agents
_xtherapeutic use
650 0 4 _aBCG Vaccine
_xadministration & dosage
650 0 4 _aCattle
650 0 4 _aCombined Modality Therapy
650 0 4 _aDiagnosis, Differential
650 0 4 _aHip Prosthesis
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMycobacterium bovis
_xisolation & purification
650 0 4 _aNeoplasm Recurrence, Local
650 0 4 _aProsthesis-Related Infections
_xdiagnosis
650 0 4 _aPyrazinamide
_xtherapeutic use
650 0 4 _aTuberculosis, Bovine
_xdiagnosis
650 0 4 _aUrinary Bladder Neoplasms
700 1 _aElzweig, Joel
773 0 _tBMJ case reports
_gvol. 12
_gno. 12
856 4 0 _uhttps://doi.org/10.1136/bcr-2019-231830
_zAvailable from publisher's website
999 _c30440289
_d30440289